Profibrinolytic effects of rivaroxaban are mediated by thrombin-activatable fibrinolysis inhibitor and are attenuated by a naturally occurring stabilizing mutation in enzyme
Garabon, Justin J. W., Boffa, Michael B.
Published in Journal of thrombosis and thrombolysis (01.08.2023)
Published in Journal of thrombosis and thrombolysis (01.08.2023)
Get full text
Journal Article
Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR
Komnenov, D, Scipione, C A, Bazzi, Z A, Garabon, J J W, Koschinsky, M L, Boffa, M B
Published in Thrombosis and haemostasis (2015)
Published in Thrombosis and haemostasis (2015)
Get more information
Journal Article